Main conclusion
In a case-control study, a PFAS mixture was associated with PCOS, higher total testosterone, and a lower FSH-to-LH ratio. This is a research signal, not evidence that PFAS cause the disorder or that a so-called detox can treat hormonal abnormalities.
What was studied
The analysis included 109 women with PCOS and 96 healthy controls. Serum concentrations of 19 PFAS were measured by UPLC-MS/MS, and 11 compounds detected in more than 80% of participants entered mixture models. PFDS and PFTrDA made relatively large contributions. Exploratory mediation suggested a possible indirect role for the DHT-to-testosterone ratio.
Key limitations
The case-control design cannot establish temporal order. Reverse causation, dietary differences, other exposure sources, and residual confounding remain possible. Multiple compounds, models, and mediators increase the chance of false-positive findings. DHT/TT is a surrogate rather than a direct measure of the full steroid pathway.
What this means in practice
PFAS measurements should not be used to diagnose PCOS, and detox claims are unsupported. Prospective cohorts, repeated exposure measurements, and mechanistic validation are needed.
Source
Clinica Chimica Acta, 2026. DOI: https://doi.org/10.1016/j.cca.2026.121314 PubMed: https://pubmed.ncbi.nlm.nih.gov/42697354/
Educational material; it does not replace individual medical advice.